19,043 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Acquired by Proficio Capital Partners LLC
Proficio Capital Partners LLC purchased a new position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the 4th quarter, Holdings Channel reports. The firm purchased 19,043 shares of the biopharmaceutical company’s stock, valued at approximately $1,590,000. A number of other institutional investors also recently bought and sold shares of ITCI. Wasatch Advisors […]
